Page last updated: 2024-11-07

dehydroepiandrosterone and Depression

dehydroepiandrosterone has been researched along with Depression in 88 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research Excerpts

ExcerptRelevanceReference
"The associations between endogenous dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), and depression in older women are uncertain."9.41Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies. ( Bell, RJ; Davis, SR; Hemachandra, C; Islam, RM; Sultana, F, 2023)
"Dehydroepiandrosterone (DHEA) has been reported to improve fatigue and reduced well-being."9.14Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. ( Bijl, M; Bijlsma, JW; Derksen, RH; Geenen, R; Godaert, GL; Hartkamp, A, 2010)
"Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) age-related withdrawal is very likely to be involved in the aging process and the onset of age-related diseases, giving rise to the question of whether preventing or compensating the decline of these steroids may have endocrine and clinical benefits."9.11Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. ( Bernardi, F; Genazzani, AD; Genazzani, AR; Inglese, S; Lombardi, I; Luisi, M; Pieri, M; Rovati, L, 2004)
"Dehydroepiandrosterone improves well-being and sexuality in women with adrenal insufficiency."9.09Dehydroepiandrosterone replacement in women with adrenal insufficiency. ( Allolio, B; Arlt, W; Bidlingmaier, M; Callies, F; Ernst, M; Huebler, D; Koehler, I; Oettel, M; Reincke, M; Schulte, HM; van Vlijmen, JC, 1999)
"An electronic search was carried out using the keywords Dehydroepiandrosterone (Mesh) AND Depression (Mesh) in the following databases: Medical Literature databases Analysis and Retrieval System Online (Medline), Excerpta Medical Database (EMBASE), Latin American and Caribbean Health Sciences (LILACS) and the Cochrane Library through their website for relevant publications until June 2018."8.98Dehydroepiandrosterone (DHEA) for Depression: A Systematic Review and Meta-Analysis. ( Cardoso, A; Grande, AJ; Mallmann, MB; Nardi, AE; Peixoto, C; Veras, AB, 2018)
" We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects."7.70Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999)
"These findings suggest that DHEA treatment induced depression-like behavior in PCOS mice, possibly through down-regulation of brain monoamines and/or their metabolites, which implies the contribution of hyperandrogenism to the psychological symptoms of women with PCOS."5.43Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome. ( Hao, S; Kang, J; Shen, Q; Song, X; Wang, H; Yu, Q, 2016)
"The associations between endogenous dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), and depression in older women are uncertain."5.41Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies. ( Bell, RJ; Davis, SR; Hemachandra, C; Islam, RM; Sultana, F, 2023)
"Depression was assessed using Beck Depression Inventory (BDI) and defined as BDI > or =16 points."5.36Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure. ( Banasiak, W; Borodulin-Nadzieja, L; Drohomirecka, A; Jankowska, EA; Lopuszanska, M; Ponikowska, B; Ponikowski, P; Poole-Wilson, PA; Szklarska, A; Witkowska, A, 2010)
"The 3α,5α- and 3α,5β-reduced metabolites of progesterone, deoxycorticosterone, and dehydroepiandrosterone (DHEA) have potent effects on neurotransmission mediated by GABA(A) receptors, and dysregulation of these receptors has been implicated in depression."5.16A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. ( Girdler, SS; Johnson, JL; Lindgren, M; Morrow, AL; Porcu, P; Rubinow, DR, 2012)
"Dehydroepiandrosterone (DHEA) has been reported to improve fatigue and reduced well-being."5.14Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. ( Bijl, M; Bijlsma, JW; Derksen, RH; Geenen, R; Godaert, GL; Hartkamp, A, 2010)
"Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) age-related withdrawal is very likely to be involved in the aging process and the onset of age-related diseases, giving rise to the question of whether preventing or compensating the decline of these steroids may have endocrine and clinical benefits."5.11Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. ( Bernardi, F; Genazzani, AD; Genazzani, AR; Inglese, S; Lombardi, I; Luisi, M; Pieri, M; Rovati, L, 2004)
"Dehydroepiandrosterone improves well-being and sexuality in women with adrenal insufficiency."5.09Dehydroepiandrosterone replacement in women with adrenal insufficiency. ( Allolio, B; Arlt, W; Bidlingmaier, M; Callies, F; Ernst, M; Huebler, D; Koehler, I; Oettel, M; Reincke, M; Schulte, HM; van Vlijmen, JC, 1999)
" This paper reviews the scientific literature published between 1990 and 2000 investigating the effects of oestrogen, testosterone and dehydroepiandrosterone (DHEA) on depression and dementia."4.81Sex hormones and their impact on dementia and depression: a clinical perspective. ( Almeida, OP; Barclay, L, 2001)
"The purpose of this prospective study was to investigate the effect of nonsurgical periodontal treatment (PT) on anxiety/depression scale scores and on gingival crevicular fluid (GCF) cortisol (COR) and dehydroepiandrosterone (DHEA) levels."3.91The effect of nonsurgical periodontal treatment on gingival crevicular fluid stress hormone levels: A prospective study. ( Alkan, BA; Cakmak, O; Saatci, E; Tasdemir, Z, 2019)
"The following variables were analyzed: passive and stimulated saliva flow, stress levels and phase, depression, anxiety, serum cortisol and dehydroepiandrosterone (DHEA) levels, and the presence of polymorphisms in the interleukin 6 (IL-6) gene."3.83Comparative Analysis of Psychological, Hormonal, and Genetic Factors Between Burning Mouth Syndrome and Secondary Oral Burning. ( AraújoMouraLemos, TM; Barbosa, NG; da Silveira, EJ; das Neves de Araújo Lima, E; de Medeiros, AM; de Souza, CM; Dos Santos, AC; Trevilatto, PC, 2016)
"Major depression have been associated with cortisol and dehydroepiandrosterone (DHEA) changes in old depressed patients."3.83Cortisol, DHEA, and depression in the elderly: the influence of physical capacity. ( Corrêa, H; Deslandes, A; Laks, J; Maciel-Pinheiro, Pde T; Moraes, H, 2016)
"The aim of this study was to determine the salivary levels of dehydroepiandrosterone (DHEA) and cortisol and scores of depression, anxiety and stress in patients with oral lichen planus (OLP)."3.77Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. ( Cherubini, K; de Figueiredo, MA; Girardi, C; Luz, C; Nunes, ML; Salum, FG, 2011)
" The purpose of this study was to investigate the motor function, anxiety levels, depression-related emotional responses, attentional function and plasma levels of testosterone and dehydroepiandrosterone (DHEA) in SAMP10."3.76Depression-like behavior and reduced plasma testosterone levels in the senescence-accelerated mouse. ( Egashira, N; Fujiwara, M; Iwasaki, K; Koushi, E; Mishima, K; Oishi, R; Okuno, R; Shirakawa, A, 2010)
" The secondary objectives were as follows: to describe demographic and clinical characteristics of male patients with FM; to evaluate basal levels of dehydroepiandrosterone sulfate (DHEAS) and total testosterone in both groups; and to investigate the relationship among pain, tender points, anxiety, and depression in these patients."3.76A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression. ( Helfenstein, M; Heymann, RE; Pollak, DF; Yoshikawa, GT, 2010)
"This study was conducted to evaluate salivary dehydroepiandrosterone (DHEA) levels, salivary flow rate (SFR), depression, and hopelessness in patients with the complaint of burning mouth (BM)."3.75Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study. ( Bandeira, D; Cherubini, K; Dias Fernandes, CS; Luz, C; Pawlowski, J; Salum, FG, 2009)
" Fifteen non-CNS-SLE patients, 15 RA patients and 15 HC participants similar in age, education, and gender (female) were compared on tests of cognition, depression, and plasma levels of interleukin-6 (IL-6), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S) and cortisol."3.71Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. ( Kozora, E; Laudenslager, M; Lemieux, A; West, SG, 2001)
" We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects."3.70Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999)
"iv) The description of chronic fatigue syndrome as regards the endocrinological, epidemiological and psychiatric characteristics are in good agreement with our experience on patients having interstitial pneumonia, evidence in support of our proposal that there is no convincing reasoning to separate chronic fatigue syndrome from interstitial pneumonia."2.71The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. ( Kodama, M; Kodama, T, 2005)
"Depression is a mental disorder that affects millions of people around the world."2.66Dehydroepiandrosterone for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials. ( Barciela Veras, A; Cardoso, A; Gomes Carrilho, C; José Grande, A; Nardi, AE; Peixoto, C, 2020)
"Dehydroepiandrosterone (DHEA) has been studied as an agent to improve HRQOL in these patients."2.45A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. ( Alkatib, AA; Cosma, M; Elamin, MB; Erickson, D; Erwin, PJ; Montori, VM; Swiglo, BA, 2009)
"Depression was assessed using the Mood and Feelings Questionnaire (MFQ) and clinical interview."1.48The association between pubertal status and depressive symptoms and diagnoses in adolescent females: A population-based cohort study. ( Goodyer, I; Ioannidis, K; Jones, PB; Lewis, G; Neufeld, S; Stochl, J; van Harmelen, AL, 2018)
"These findings suggest that DHEA treatment induced depression-like behavior in PCOS mice, possibly through down-regulation of brain monoamines and/or their metabolites, which implies the contribution of hyperandrogenism to the psychological symptoms of women with PCOS."1.43Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome. ( Hao, S; Kang, J; Shen, Q; Song, X; Wang, H; Yu, Q, 2016)
"Patients with temporomandibular disorders (TMD) commonly experience myofascial and joint pain, pain-related disability, and other pain conditions including depression."1.43Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. ( Ahn, RS; Jo, KB; Lee, IG; Lee, SC; Lee, YJ; Park, JY, 2016)
"Posttraumatic stress disorder (PTSD) is associated with increased morbidity and mortality through somatic conditions, particularly cardiovascular disease."1.42Altered one-carbon metabolism in posttraumatic stress disorder. ( Assies, J; de Vries, GJ; Lok, A; Mocking, R; Olff, M; Schene, A, 2015)
"Patients with chronic periodontitis (CP) and those with healthy periodontal tissues/mild gingivitis were included."1.40Association of gingival crevicular fluid cortisol/dehydroepiandrosterone levels with periodontal status. ( Abdulrezzak, U; Alkan, BA; Cakmak, O; Ozsoy, S; Sen, A, 2014)
"Both the event of rape and PTSD diagnosis, and not factors such as sleep duration, smoking, education or oral contraceptives, accounted for the neuroendocrine differences between rape victims and controls."1.39Salivary cortisol and dehydroepiandrosterone sulfate in adolescent rape victims with post traumatic stress disorder. ( Bicanic, IA; De Roos, C; Olff, M; Postma, RM; Sinnema, G; Van de Putte, EM; Van Wesel, F, 2013)
"Depression was assessed using Beck Depression Inventory (BDI) and defined as BDI > or =16 points."1.36Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure. ( Banasiak, W; Borodulin-Nadzieja, L; Drohomirecka, A; Jankowska, EA; Lopuszanska, M; Ponikowska, B; Ponikowski, P; Poole-Wilson, PA; Szklarska, A; Witkowska, A, 2010)
"Previous research suggests that in borderline personality disorder (BPD) normal stress regulation, with a main role for cortisol, is disturbed."1.34Basal cortisol and DHEA levels in women with borderline personality disorder. ( de Knijff, DW; Jogems-Kosterman, BJ; Kusters, R; van Hoof, JJ, 2007)
"Depressive symptoms, smoking withdrawal symptoms, and plasma steroid levels were measured before and after 8 days of verified smoking abstinence."1.33A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study. ( Anderson, GM; Krishnan-Sarin, S; Paliwal, P; Rasmusson, AM; Wu, R, 2006)

Research

Studies (88)

TimeframeStudies, this research(%)All Research%
pre-19903 (3.41)18.7374
1990's11 (12.50)18.2507
2000's30 (34.09)29.6817
2010's36 (40.91)24.3611
2020's8 (9.09)2.80

Authors

AuthorsStudies
Hatipoglu, E1
Hacioglu, Y1
Polat, Y1
Arslan, HF1
Oner, S1
Ekmekci, OB1
Niyazoglu, M1
Hemachandra, C1
Davis, SR1
Bell, RJ1
Sultana, F1
Islam, RM1
Agorastos, A1
Heinig, A1
Sommer, A1
Wiedemann, K1
Demiralay, C1
Pang, RD1
Tucker, CJ1
Guillot, CR1
Belcher, B1
Kirkpatrick, MG1
Micol, VJ1
Roberts, AG1
Taylor-Cavelier, SJ1
Geiss, EG1
Lopez-Duran, N1
Froger, N1
Mukerji, SS1
Misra, V1
Lorenz, DR1
Chettimada, S1
Keller, K1
Letendre, S1
Ellis, RJ1
Morgello, S1
Parker, RA1
Gabuzda, D1
Alghadir, AH1
Gabr, SA1
Peixoto, C3
José Grande, A1
Gomes Carrilho, C1
Nardi, AE3
Cardoso, A3
Barciela Veras, A1
Chronister, BN1
Gonzalez, E1
Lopez-Paredes, D1
Suarez-Torres, J1
Gahagan, S1
Martinez, D1
Barros, J1
Jacobs, DR1
Checkoway, H1
Suarez-Lopez, JR1
Kent, M1
Bardi, M2
Hazelgrove, A1
Sewell, K1
Kirk, E1
Thompson, B1
Trexler, K1
Terhune-Cotter, B1
Lambert, K1
Samardzic, J1
Hencic, B1
Jancic, J1
Jadzic, D1
Djuric, M1
Obradovic, DI1
Svob Strac, D1
Hassan, K1
Elimeleh, Y1
Shehadeh, M1
Hassan, F1
Rubinchik, I1
Lewis, G2
Ioannidis, K1
van Harmelen, AL1
Neufeld, S1
Stochl, J1
Jones, PB1
Goodyer, I1
Ng, KST1
Sia, A1
Ng, MKW1
Tan, CTY1
Chan, HY1
Tan, CH1
Rawtaer, I1
Feng, L1
Mahendran, R1
Larbi, A1
Kua, EH1
Ho, RCM1
Grande, AJ1
Mallmann, MB1
Veras, AB2
Cakmak, O2
Alkan, BA2
Saatci, E1
Tasdemir, Z1
Ellis, R1
Fernandes, A1
Simmons, JG2
Mundy, L1
Patton, G1
Allen, NB2
Whittle, S2
Walther, A2
Tsao, C1
Pande, R1
Kirschbaum, C1
Field, E1
Berkman, L1
Moriguchi, S1
Shinoda, Y1
Yamamoto, Y1
Sasaki, Y1
Miyajima, K1
Tagashira, H1
Fukunaga, K1
Duggal, NA1
Beswetherick, A1
Upton, J1
Hampson, P1
Phillips, AC1
Lord, JM1
Ozsoy, S1
Sen, A1
Abdulrezzak, U1
Pluchino, N1
Drakopoulos, P1
Bianchi-Demicheli, F1
Wenger, JM1
Petignat, P1
Genazzani, AR2
Devicari Cheda, JN1
de Vries, GJ1
Lok, A1
Mocking, R1
Assies, J1
Schene, A1
Olff, M2
Rabijewski, M1
Papierska, L1
Kuczerowski, R1
Piątkiewicz, P1
Delany, FM1
Byrne, ML1
Olsson, C1
Mundy, LK1
Patton, GC1
das Neves de Araújo Lima, E1
Barbosa, NG1
Dos Santos, AC1
AraújoMouraLemos, TM1
de Souza, CM1
Trevilatto, PC1
da Silveira, EJ1
de Medeiros, AM1
Jo, KB1
Lee, YJ1
Lee, IG1
Lee, SC1
Park, JY1
Ahn, RS1
Kobayashi, M1
Sugiyama, N1
Sasayama, D1
Sasamoto, H1
Miyashiro, Y1
Arima, K1
Washizuka, S1
Moraes, H1
Deslandes, A1
Maciel-Pinheiro, Pde T1
Corrêa, H1
Laks, J1
Yu, Q1
Hao, S1
Wang, H1
Song, X1
Shen, Q1
Kang, J1
Philipp, M1
Lozza, N1
Ehlert, U1
Šrámková, M1
Dušková, M1
Hill, M1
Bičíková, M1
Řípová, D1
Mohr, P1
Stárka, L1
Maninger, N1
Wolkowitz, OM3
Reus, VI2
Epel, ES1
Mellon, SH1
Yoshikawa, GT1
Heymann, RE1
Helfenstein, M1
Pollak, DF1
Alkatib, AA1
Cosma, M1
Elamin, MB1
Erickson, D1
Swiglo, BA1
Erwin, PJ1
Montori, VM1
Dias Fernandes, CS1
Salum, FG2
Bandeira, D1
Pawlowski, J1
Luz, C2
Cherubini, K2
Hartkamp, A1
Geenen, R1
Godaert, GL1
Bijl, M1
Bijlsma, JW1
Derksen, RH1
Egashira, N1
Koushi, E1
Okuno, R1
Shirakawa, A1
Mishima, K1
Iwasaki, K1
Oishi, R1
Fujiwara, M1
Jankowska, EA1
Drohomirecka, A1
Ponikowska, B1
Witkowska, A1
Lopuszanska, M1
Szklarska, A1
Borodulin-Nadzieja, L1
Banasiak, W1
Poole-Wilson, PA1
Ponikowski, P1
Girardi, C1
de Figueiredo, MA1
Nunes, ML1
Girdler, SS1
Lindgren, M1
Porcu, P1
Rubinow, DR1
Johnson, JL1
Morrow, AL1
Traish, AM1
Kang, HP1
Saad, F1
Guay, AT1
Rhone, AP1
Franssen, CL1
Hampton, JE1
Shea, EA1
Hyer, MM1
Huber, J1
Lambert, KG1
Colangelo, LA1
Craft, LL1
Ouyang, P1
Liu, K1
Schreiner, PJ1
Michos, ED1
Gapstur, SM1
Bicanic, IA1
Postma, RM1
Sinnema, G1
De Roos, C1
Van Wesel, F1
Van de Putte, EM1
Schmidt, PJ1
Murphy, JH1
Haq, N1
Danaceau, MA1
St Clair, L1
Hyyppä, MT1
Kronholm, E1
Virtanen, A1
Leino, A1
Jula, A1
Angold, A1
Nadjafi-Triebsch, C1
Huell, M1
Burki, D1
Rohr, UD1
Patel, BN1
Pang, D1
Stern, Y1
Silverman, W1
Kline, JK1
Mayeux, R1
Schupf, N1
Pico-Alfonso, MA1
Garcia-Linares, MI1
Celda-Navarro, N1
Herbert, J1
Martinez, M1
Kodama, M1
Kodama, T1
Inglese, S1
Lombardi, I1
Pieri, M1
Bernardi, F1
Genazzani, AD1
Rovati, L1
Luisi, M1
Maayan, R3
Morad, O1
Dorfman, P1
Overstreet, DH1
Weizman, A3
Yadid, G2
Eser, D1
Schüle, C1
Romeo, E1
Baghai, TC1
di Michele, F1
Pasini, A1
Zwanzger, P1
Padberg, F1
Rupprecht, R1
Ryff, CD1
Dienberg Love, G1
Urry, HL1
Muller, D1
Rosenkranz, MA1
Friedman, EM1
Davidson, RJ1
Singer, B1
Rasmusson, AM1
Wu, R1
Paliwal, P1
Anderson, GM1
Krishnan-Sarin, S1
Shamlian, NT1
Cole, MG1
Jogems-Kosterman, BJ1
de Knijff, DW1
Kusters, R1
van Hoof, JJ1
Touati-Werner, D1
Ram, E1
Strous, R1
Keren, O1
Goldman, N1
Glei, DA1
Genud, R1
Merenlender, A1
Gispan-Herman, I1
Derogatis, LR1
Rose, LI2
Shulman, LH2
Lazarus, LA1
Roberts, E1
Manfredi, F1
Chan, T1
Ormiston, S1
Johnson, R1
Canick, J1
Brizendine, L1
Weingartner, H2
Cawood, EH1
Bancroft, J1
Morrison, MF1
Ravaglia, G1
Forti, P1
Maioli, F1
Boschi, F1
Cicognani, A1
Bernardi, M1
Pratelli, L1
Pizzoferrato, A1
Porcu, S1
Gasbarrini, G1
Prasad, A1
Imamura, M1
Prasad, C1
Heuser, I1
Deuschle, M1
Luppa, P1
Schweiger, U1
Standhardt, H1
Weber, B1
Arlt, W1
Callies, F1
van Vlijmen, JC1
Koehler, I1
Reincke, M1
Bidlingmaier, M1
Huebler, D1
Oettel, M1
Ernst, M1
Schulte, HM1
Allolio, B1
Heinz, A1
George, D1
Hommer, D1
Linnoila, M1
Cyr, M1
Calon, F1
Morissette, M1
Grandbois, M1
Di Paolo, T1
Callier, S1
Almeida, OP1
Barclay, L1
Rabkin, J1
Kozora, E1
Laudenslager, M1
Lemieux, A1
West, SG1
Gallagher, P1
Young, A1
Vermeulen, A1
Suy, E1
Rubens, R1
DeRogatis, L1
Spielvogel, R1
Miller, JL1
Mendels, J1
Sclare, AB1
Grant, JK1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living With HIV[NCT05570812]Phase 2120 participants (Anticipated)Interventional2023-03-03Recruiting
The Effect Of Horticultural Therapy On The Level Of Happiness And Loneliness Of Elderly Living In Nursing Home[NCT04291183]50 participants (Anticipated)Interventional2020-03-11Not yet recruiting
Pilot Evaluation of Technology-enhanced Horticultural Activities Among the People With Dementia and Their Family Caregivers[NCT05577975]60 participants (Anticipated)Interventional2022-09-01Recruiting
Relationship Between Central Sensitization and Alteration of Circulating Neurosteroid Following Bilateral Total Knee Arthroplasty[NCT03298711]69 participants (Actual)Observational2017-11-20Completed
The Interplay Between Addiction to Tobacco Smoking and Sleep Quality Among Healthy Adults[NCT04265339]150 participants (Anticipated)Interventional2018-10-15Recruiting
Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration[NCT00391924]Phase 2120 participants Interventional2000-05-31Completed
The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation on the Number of Oocytes Obtained During IVF in Poor Ovarian Responders[NCT02357472]Phase 450 participants (Anticipated)Interventional2014-12-31Active, not recruiting
Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD[NCT02382848]9 participants (Actual)Interventional2015-07-31Completed
Longitudinal Measurement of Cortisol in Association With Mental Health and Experience of Domestic Violence and Abuse[NCT01632553]214 participants (Actual)Observational2012-08-31Completed
Effects of Omega-3 Fatty Acids on Bone and Frailty[NCT00634686]Phase 4150 participants (Anticipated)Interventional2007-01-31Active, not recruiting
Dehydroepiandrosterone(DHEA) Substitution in Adolescent and Young Women With Central Adrenal Insufficiency. A Multicenter, Randomised Double Blind Trial[NCT00575341]Phase 323 participants (Actual)Interventional2003-10-31Completed
Early Mental Response to Hormonal Treatment in Transgender Men - The EMRE Study[NCT05649605]70 participants (Anticipated)Interventional2023-03-07Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Decrease in Bulimia Symptoms

EDI-3 (Eating Disorder Inventory 3 Scale) is a pencil and paper test consisting of 91 items and 12 sub-scales. The main scales are the drive for thinness and the bulimia scales, the remaining sub-scales are: low self-esteem, body dissatisfaction, maturity fears, personal alienation, interpersonal alienation, interpersonal insecurity, perfectionism, interoceptive deficits, emotional dysregulation, and asceticism. The response options are based on a 6-point Likert-type scale are: Always, Usually, Often, Sometimes, Rarely, and Never. There are six composite scores, 12 primary scores, and three response style validity indicators. Software is used to calculate the raw scores, composite scores, validity scale scores and the T-scores. The t-score for the Bulimia scale will be used for this analysis with a range of 22-66. Higher scores indicate the likelihood of an eating disorder. A higher t-score on the bulimia scale indicates a worse outcome. (NCT02382848)
Timeframe: 3 weeks

InterventionT-Score (Mean)
Prazosin43.1
Placebo38.6

Decrease in Depressed Mood as Measured by the HDRS (Hamilton Depression Rating Scale) and Subject Interview

Rating scales and subject interview will be used to determine if there is a decrease in depressed mood among participants undergoing drug intervention. The HDRS (Hamilton Depression Rating Scale) consists of 17 items, some scored on a 5-point scale (0-4) and others scored on a 3-point scale (0-2). Items from the scale can be summed to give a total score ranging from 0 to 50, with higher scores indicating a worse outcome. This analysis is based on a single item from the scale (Depressed Mood, measured on a 5-point scale) where a higher score again indicates a worse outcome. (NCT02382848)
Timeframe: 3 weeks

Interventionscore on a scale (Mean)
Prazosin1.4
Placebo1.3

Decrease in Frequency of Nightmares Using the Sleep-50 Questionnaire

"The individual question about frightening dreams from the Nightmares Subscale of a self-administered questionnaire (Sleep-50 Questionnaire), will be used to determine if there is a decrease in frequency of nightmares in patients undergoing drug intervention. For each question, respondents are provided with a scale ranging from 1 (not at all) to 4 (very much) and are asked to indicate the extent to which the statement has matched their experience over the study time frame. The scale values range from 1-4, where a lower value indicates lower frequency of nightmares. A higher score is a worse outcome." (NCT02382848)
Timeframe: 3 weeks

Interventionscore on a scale (Mean)
Prazosin2.25
Placebo2.75

Decrease in Self Harm Thoughts as Measured by the HDRS and Subject Interview

Rating scales and subject interview will be used to determine if there is a decrease in self harm among participants undergoing drug intervention. The HDRS (Hamilton Depression Rating Scale) consists of 17 items, some scored on a 5-point scale (0-4) and others scored on a 3-point scale (0-2). Items from the scale can be summed to give a total score ranging from 0 to 50, with higher scores indicating a worse outcome. This analysis is based on a single item from the scale (Self Harm, measured on a 5-point scale) where a higher score again indicates a worse outcome. (NCT02382848)
Timeframe: 3 weeks

Interventionscore on a scale (Mean)
Prazosin0.5
Placebo.1

Decrease in Total CAPS Score (PTSD)

The CAPS (Clinician administered PTSD) rating scale consists of 30 questions rated on a 0-4 point scoring system and patient interview will be used to determine if there is a decrease in PTSD Symptoms among participants undergoing drug intervention. 17 of these questions are used to calculate the total severity score used in this analysis. This is done by summing the frequency and intensity ratings (each ranging from 0-4) for each of the 17 questions. The total severity score can have a range of 0-136. A higher score on this scale indicates a worse outcome. (NCT02382848)
Timeframe: 3 weeks

Interventionscore on a scale (Mean)
Prazosin65.5
Placebo79.8

Reviews

12 reviews available for dehydroepiandrosterone and Depression

ArticleYear
Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies.
    Menopause (New York, N.Y.), 2023, 03-01, Volume: 30, Issue:3

    Topics: Affect; Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Ob

2023
[New therapeutic avenues for neurosteroids in psychiatric diseases].
    Biologie aujourd'hui, 2019, Volume: 213, Issue:3-4

    Topics: Animals; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Drugs, Investigational;

2019
Dehydroepiandrosterone for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials.
    Journal of neuroscience research, 2020, Volume: 98, Issue:12

    Topics: Adjuvants, Immunologic; Dehydroepiandrosterone; Depression; Female; Humans; Male; Randomized Control

2020
Dehydroepiandrosterone (DHEA) for Depression: A Systematic Review and Meta-Analysis.
    CNS & neurological disorders drug targets, 2018, Volume: 17, Issue:9

    Topics: Antidepressive Agents; Databases, Factual; Dehydroepiandrosterone; Depression; Humans

2018
Neurobiology of DHEA and effects on sexuality, mood and cognition.
    The Journal of steroid biochemistry and molecular biology, 2015, Volume: 145

    Topics: Affect; Animals; Anxiety; Brain; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dehydroepia

2015
The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review.
    Current drug targets, 2014, Volume: 15, Issue:9

    Topics: Adrenal Insufficiency; Anorexia Nervosa; Antidepressive Agents; Databases, Bibliographic; Dehydroepi

2014
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).
    Frontiers in neuroendocrinology, 2009, Volume: 30, Issue:1

    Topics: Adult; Aged; Aging; Animals; Antioxidants; Brain; Dehydroepiandrosterone; Dehydroepiandrosterone Sul

2009
A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:10

    Topics: Adrenal Insufficiency; Anxiety; Dehydroepiandrosterone; Depression; Health Status; Humans; Quality o

2009
Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.
    The journal of sexual medicine, 2011, Volume: 8, Issue:11

    Topics: Aging; Animals; Body Composition; Bone and Bones; Cardiovascular Diseases; Dehydroepiandrosterone; D

2011
Androgen treatment of depressive symptoms in older men: a systematic review of feasibility and effectiveness.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2006, Volume: 51, Issue:5

    Topics: Dehydroepiandrosterone; Depression; Feasibility Studies; Humans; Randomized Controlled Trials as Top

2006
Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.
    Current pharmaceutical design, 2000, Volume: 6, Issue:12

    Topics: Alzheimer Disease; Animals; Brain; Dehydroepiandrosterone; Depression; Estrogens; Female; Humans; Ma

2000
Sex hormones and their impact on dementia and depression: a clinical perspective.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4

    Topics: Alzheimer Disease; Dehydroepiandrosterone; Depression; Estrogens; Gonadal Steroid Hormones; Humans;

2001

Trials

8 trials available for dehydroepiandrosterone and Depression

ArticleYear
Effects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled Trial.
    International journal of environmental research and public health, 2018, 08-09, Volume: 15, Issue:8

    Topics: Aged; Anxiety; Asian People; Brain; Brain-Derived Neurotrophic Factor; Chemokine CXCL12; Cognition;

2018
Effects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled Trial.
    International journal of environmental research and public health, 2018, 08-09, Volume: 15, Issue:8

    Topics: Aged; Anxiety; Asian People; Brain; Brain-Derived Neurotrophic Factor; Chemokine CXCL12; Cognition;

2018
Effects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled Trial.
    International journal of environmental research and public health, 2018, 08-09, Volume: 15, Issue:8

    Topics: Aged; Anxiety; Asian People; Brain; Brain-Derived Neurotrophic Factor; Chemokine CXCL12; Cognition;

2018
Effects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled Trial.
    International journal of environmental research and public health, 2018, 08-09, Volume: 15, Issue:8

    Topics: Aged; Anxiety; Asian People; Brain; Brain-Derived Neurotrophic Factor; Chemokine CXCL12; Cognition;

2018
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:6

    Topics: Adult; Aged; Dehydroepiandrosterone; Depression; Double-Blind Method; Fatigue; Female; Follow-Up Stu

2010
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:6

    Topics: Adult; Aged; Dehydroepiandrosterone; Depression; Double-Blind Method; Fatigue; Female; Follow-Up Stu

2010
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:6

    Topics: Adult; Aged; Dehydroepiandrosterone; Depression; Double-Blind Method; Fatigue; Female; Follow-Up Stu

2010
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:6

    Topics: Adult; Aged; Dehydroepiandrosterone; Depression; Double-Blind Method; Fatigue; Female; Follow-Up Stu

2010
A history of depression in women is associated with an altered GABAergic neuroactive steroid profile.
    Psychoneuroendocrinology, 2012, Volume: 37, Issue:4

    Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Double-Blind Method; Female; Humans

2012
Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial.
    Psychoneuroendocrinology, 2003, Volume: 28, Issue:2

    Topics: Adult; Affect; Anticholesteremic Agents; Cross-Over Studies; Dehydroepiandrosterone; Depression; Die

2003
The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex.
    International journal of molecular medicine, 2005, Volume: 15, Issue:1

    Topics: Adult; Aged; Ascorbic Acid; Dehydroepiandrosterone; Depression; Fatigue Syndrome, Chronic; Female; F

2005
Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2004, Volume: 7, Issue:2

    Topics: Aged; Aging; Androgens; Andropause; Arthralgia; beta-Endorphin; Dehydroepiandrosterone; Dehydroepian

2004
Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    The New England journal of medicine, 1999, Sep-30, Volume: 341, Issue:14

    Topics: Adrenal Insufficiency; Adult; Affect; Androgens; Anxiety; Cross-Over Studies; Dehydroepiandrosterone

1999
Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    The New England journal of medicine, 1999, Sep-30, Volume: 341, Issue:14

    Topics: Adrenal Insufficiency; Adult; Affect; Androgens; Anxiety; Cross-Over Studies; Dehydroepiandrosterone

1999
Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    The New England journal of medicine, 1999, Sep-30, Volume: 341, Issue:14

    Topics: Adrenal Insufficiency; Adult; Affect; Androgens; Anxiety; Cross-Over Studies; Dehydroepiandrosterone

1999
Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    The New England journal of medicine, 1999, Sep-30, Volume: 341, Issue:14

    Topics: Adrenal Insufficiency; Adult; Affect; Androgens; Anxiety; Cross-Over Studies; Dehydroepiandrosterone

1999
DHEA for depression?
    TreatmentUpdate, 2001,Winter, Volume: 12, Issue:10

    Topics: Affect; Body Composition; Dehydroepiandrosterone; Depression; Female; HIV Infections; Humans; Male;

2001

Other Studies

68 other studies available for dehydroepiandrosterone and Depression

ArticleYear
Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2022, Volume: 66

    Topics: Acromegaly; Animals; Cognition; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression;

2022
Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of depression: An HPA axis challenge study.
    Journal of psychiatric research, 2023, Volume: 161

    Topics: Adrenocorticotropic Hormone; Biomarkers; Dehydroepiandrosterone; Depression; Depressive Disorder, Ma

2023
Associations of DHEA(S) with negative and positive affect in people who smoke daily with elevated and low depression symptoms: A pilot laboratory study.
    Addictive behaviors, 2023, Volume: 146

    Topics: Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Humans; Smoking; Smoking Cessati

2023
Early trauma moderates the link between familial risk for depression and post-stress DHEA/cortisol ratios in adolescents.
    Psychoneuroendocrinology, 2019, Volume: 110

    Topics: Adolescent; Child; Dehydroepiandrosterone; Depression; Family; Female; Humans; Hydrocortisone; Hypot

2019
Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
    The Journal of infectious diseases, 2021, 05-20, Volume: 223, Issue:9

    Topics: Adult; Dehydroepiandrosterone; Depression; HIV Infections; Humans; Hydrocortisone; Hypothalamo-Hypop

2021
Hormonal Function Responses to Moderate Aerobic Exercise in Older Adults with Depression.
    Clinical interventions in aging, 2020, Volume: 15

    Topics: Aged; Aged, 80 and over; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Exercis

2020
Testosterone, estradiol, DHEA and cortisol in relation to anxiety and depression scores in adolescents.
    Journal of affective disorders, 2021, 11-01, Volume: 294

    Topics: Adolescent; Anxiety; Cross-Sectional Studies; Dehydroepiandrosterone; Depression; Estradiol; Female;

2021
Profiling coping strategies in male and female rats: Potential neurobehavioral markers of increased resilience to depressive symptoms.
    Hormones and behavior, 2017, Volume: 95

    Topics: Adaptation, Psychological; Animals; Behavior, Animal; Biomarkers; Brain; Corticosterone; Dehydroepia

2017
Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats.
    Neuroscience letters, 2017, Nov-01, Volume: 660

    Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Dehydroepiandrosterone; Depres

2017
Associations of Peritoneal Glucose Load With Male Sexual Dysfunction and Depression in Peritoneal Dialysis Patients.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2018, Volume: 22, Issue:4

    Topics: Aged; Cross-Sectional Studies; Dehydroepiandrosterone; Depression; Erectile Dysfunction; Estradiol;

2018
The association between pubertal status and depressive symptoms and diagnoses in adolescent females: A population-based cohort study.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Adolescent; Breast; Child; Dehydroepiandrosterone; Depression; Female; Humans; Interview, Psychologi

2018
The effect of nonsurgical periodontal treatment on gingival crevicular fluid stress hormone levels: A prospective study.
    Oral diseases, 2019, Volume: 25, Issue:1

    Topics: Adult; Anxiety; Case-Control Studies; Chronic Periodontitis; Dehydroepiandrosterone; Dental Plaque I

2019
Relationships between adrenarcheal hormones, hippocampal volumes and depressive symptoms in children.
    Psychoneuroendocrinology, 2019, Volume: 104

    Topics: Adrenal Glands; Adrenarche; Androgens; Brain; Child; Cross-Sectional Studies; Dehydroepiandrosterone

2019
Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women.
    Psychoneuroendocrinology, 2019, Volume: 109

    Topics: Adult; Aged; Aged, 80 and over; Androgens; Anxiety; Anxiety Disorders; Cohort Studies; Dehydroepiand

2019
Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Animals; Behavior, Animal; beta Catenin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dehydro

2013
Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production.
    Experimental gerontology, 2014, Volume: 54

    Topics: Aged; Aged, 80 and over; Analysis of Variance; B7-1 Antigen; B7-2 Antigen; Case-Control Studies; Cyt

2014
Association of gingival crevicular fluid cortisol/dehydroepiandrosterone levels with periodontal status.
    Journal of periodontology, 2014, Volume: 85, Issue:8

    Topics: Adult; Anxiety; Chronic Periodontitis; Cross-Sectional Studies; Dehydroepiandrosterone; Dental Plaqu

2014
Altered one-carbon metabolism in posttraumatic stress disorder.
    Journal of affective disorders, 2015, Sep-15, Volume: 184

    Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Female; Folic Acid; Homocysteine; H

2015
Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes.
    Clinical interventions in aging, 2015, Volume: 10

    Topics: Aged; Aged, 80 and over; Aging; Andropause; Dehydroepiandrosterone; Depression; Humans; Insulin-Like

2015
Depression, immune function, and early adrenarche in children.
    Psychoneuroendocrinology, 2016, Volume: 63

    Topics: Adrenarche; C-Reactive Protein; Child; Child Behavior; Cohort Studies; Dehydroepiandrosterone; Depre

2016
Comparative Analysis of Psychological, Hormonal, and Genetic Factors Between Burning Mouth Syndrome and Secondary Oral Burning.
    Pain medicine (Malden, Mass.), 2016, Volume: 17, Issue:9

    Topics: Adult; Aged; Burning Mouth Syndrome; Cross-Sectional Studies; Dehydroepiandrosterone; Depression; Fe

2016
Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders.
    Psychoneuroendocrinology, 2016, Volume: 69

    Topics: Adult; Chronic Pain; Circadian Rhythm; Comorbidity; Dehydroepiandrosterone; Depression; Depressive D

2016
Sex differences in the serum level of endogenous ligands for estrogen receptor β in the elderly population.
    Scientific reports, 2016, 05-11, Volume: 6

    Topics: Aged; Chromatography, Liquid; Dehydroepiandrosterone; Depression; Estradiol; Estrogen Receptor beta;

2016
Cortisol, DHEA, and depression in the elderly: the influence of physical capacity.
    Arquivos de neuro-psiquiatria, 2016, Volume: 74, Issue:6

    Topics: Aged; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Dehydroepiandrosterone; Depression;

2016
Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.
    Biology of reproduction, 2016, Volume: 95, Issue:4

    Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Dehydroepiandrosterone; Depression; Diet, Hig

2016
The rate of change in declining steroid hormones: a new parameter of healthy aging in men?
    Oncotarget, 2016, 09-20, Volume: 7, Issue:38

    Topics: Adult; Aged; Aging; Biomarkers; Dehydroepiandrosterone; Depression; Estradiol; Gonadal Steroid Hormo

2016
The role of steroids in the prediction of affective disorders in adult men.
    Steroids, 2017, Volume: 121

    Topics: Adult; Anxiety; Dehydroepiandrosterone; Depression; Female; Gas Chromatography-Mass Spectrometry; Hu

2017
A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression.
    Rheumatology international, 2010, Volume: 30, Issue:4

    Topics: Activities of Daily Living; Adolescent; Adult; Aged; Anxiety; Brazil; Dehydroepiandrosterone; Demogr

2010
Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 108, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Burning Mouth Syndrome; Case-Control Studies; Circadian Rhythm; Dehy

2009
Depression-like behavior and reduced plasma testosterone levels in the senescence-accelerated mouse.
    Behavioural brain research, 2010, May-01, Volume: 209, Issue:1

    Topics: Acoustic Stimulation; Aging; Analysis of Variance; Animals; Behavior, Animal; Dehydroepiandrosterone

2010
Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure.
    European journal of heart failure, 2010, Volume: 12, Issue:9

    Topics: Adult; Biomarkers; Dehydroepiandrosterone; Depression; Disease Progression; Follow-Up Studies; Heart

2010
Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus.
    Archives of oral biology, 2011, Volume: 56, Issue:9

    Topics: Adult; Anxiety; Case-Control Studies; Dehydroepiandrosterone; Depression; Female; Humans; Hydrocorti

2011
Behavioral training and predisposed coping strategies interact to influence resilience in male Long-Evans rats: implications for depression.
    Stress (Amsterdam, Netherlands), 2012, Volume: 15, Issue:3

    Topics: Adaptation, Psychological; Animals; Anxiety; Behavior, Animal; Brain; Brain Chemistry; Corticosteron

2012
Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis.
    Menopause (New York, N.Y.), 2012, Volume: 19, Issue:8

    Topics: Aged; Aged, 80 and over; Asian; Atherosclerosis; Black People; Dehydroepiandrosterone; Depression; E

2012
Salivary cortisol and dehydroepiandrosterone sulfate in adolescent rape victims with post traumatic stress disorder.
    Psychoneuroendocrinology, 2013, Volume: 38, Issue:3

    Topics: Adolescent; Adolescent Behavior; Case-Control Studies; Crime Victims; Dehydroepiandrosterone; Depres

2013
Basal plasma hormone levels in depressed perimenopausal women.
    Psychoneuroendocrinology, 2002, Volume: 27, Issue:8

    Topics: Adult; Climacteric; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Estradiol; E

2002
Adolescent depression, cortisol and DHEA.
    Psychological medicine, 2003, Volume: 33, Issue:4

    Topics: Adolescent; Adolescent Psychiatry; Circadian Rhythm; Dehydroepiandrosterone; Depression; Humans; Hyd

2003
Progesterone increase under DHEA-substitution in males.
    Maturitas, 2003, Jul-25, Volume: 45, Issue:3

    Topics: Aged; Dehydroepiandrosterone; Depression; Fatigue; Humans; Male; Middle Aged; Progesterone; Testoste

2003
Obesity enhances verbal memory in postmenopausal women with Down syndrome.
    Neurobiology of aging, 2004, Volume: 25, Issue:2

    Topics: Adult; Body Mass Index; Case-Control Studies; Dehydroepiandrosterone; Depression; Down Syndrome; Est

2004
Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence.
    Biological psychiatry, 2004, Aug-15, Volume: 56, Issue:4

    Topics: Adult; Analysis of Variance; Anxiety; Battered Women; Crime Victims; Dehydroepiandrosterone; Depress

2004
The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2005, Volume: 15, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Chemistry; Cytosol; Dehydroepiandrosterone; Dehyd

2005
DHEA: over-the-counter antidote for depression. Non-prescription hormonal supplement can help relieve minor and major depression in middle age.
    Health news (Waltham, Mass.), 2005, Volume: 11, Issue:6

    Topics: Antidepressive Agents; Dehydroepiandrosterone; Depression; Humans

2005
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.
    Psychopharmacology, 2006, Volume: 186, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Dehydroepiandrosterone; Dehydroepiandrosterone

2006
DHEA for depression.
    The Harvard mental health letter, 2005, Volume: 22, Issue:5

    Topics: Aged; Antidepressive Agents; Dehydroepiandrosterone; Depression; Humans; Middle Aged

2005
Psychological well-being and ill-being: do they have distinct or mirrored biological correlates?
    Psychotherapy and psychosomatics, 2006, Volume: 75, Issue:2

    Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Dehydroepiandrosterone; Depression; Fe

2006
A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study.
    Psychopharmacology, 2006, Volume: 186, Issue:3

    Topics: Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocort

2006
Basal cortisol and DHEA levels in women with borderline personality disorder.
    Journal of psychiatric research, 2007, Volume: 41, Issue:12

    Topics: Adaptation, Psychological; Adult; Borderline Personality Disorder; Child; Child Abuse; Dehydroepiand

2007
The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 85, Issue:2

    Topics: Animals; Anxiety; Castration; Dehydroepiandrosterone; Depression; Disease Models, Animal; Estradiol;

2006
DHEA and health: more questions than answers.
    Harvard men's health watch, 2007, Volume: 11, Issue:9

    Topics: Aging; Cognition; Coronary Artery Disease; Dehydroepiandrosterone; Depression; Dietary Supplements;

2007
Sex differences in the relationship between DHEAS and health.
    Experimental gerontology, 2007, Volume: 42, Issue:10

    Topics: Aged; Aging; Asian People; Biomarkers; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandros

2007
DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

    Topics: Animals; Antidepressive Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression;

2009
Serum androgens and psychopathology in hirsute women.
    Journal of psychosomatic obstetrics and gynaecology, 1993, Volume: 14, Issue:4

    Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate;

1993
Antidepressant and cognition-enhancing effects of DHEA in major depression.
    Annals of the New York Academy of Sciences, 1995, Dec-29, Volume: 774

    Topics: Affect; Aged; Aging; Cognition; Dehydroepiandrosterone; Depression; Female; Humans; Male; Middle Age

1995
Steroid hormones, the menopause, sexuality and well-being of women.
    Psychological medicine, 1996, Volume: 26, Issue:5

    Topics: Adult; Affect; Analysis of Variance; Chi-Square Distribution; Climacteric; Dehydroepiandrosterone; D

1996
Androgens in the elderly: will androgen replacement therapy improve mood, cognition, and quality of life in aging men and women.
    Psychopharmacology bulletin, 1997, Volume: 33, Issue:2

    Topics: Affect; Aged; Alzheimer Disease; Androgens; Cognition; Dehydroepiandrosterone; Depression; Female; G

1997
Determinants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practice.
    Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:10

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anthropometry; Dehydroepiandrosterone; Depressi

1997
Dehydroepiandrosterone decreases behavioral despair in high- but not low-anxiety rats.
    Physiology & behavior, 1997, Volume: 62, Issue:5

    Topics: Animals; Anxiety; Arousal; Corticosterone; Dehydroepiandrosterone; Depression; Fear; Helplessness, L

1997
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:9

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Aging; Body Mass Index; Circadian Rhythm; Dehydroepiandros

1998
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
    Psychiatry research, 1999, Dec-20, Volume: 89, Issue:2

    Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid;

1999
DHEA for depression.
    Treatment review, 1997, Issue:No 25

    Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Depression; Female; HIV Infections; Humans; Male;

1997
DHEA. Is it useful for treating depression?
    The Body positive, 2001, Volume: 14, Issue:8

    Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Depression; Female; HIV Infections; Humans; Male

2001
DHEA--cautions and concerns.
    TreatmentUpdate, 2001,Winter, Volume: 12, Issue:10

    Topics: Contraindications; Dehydroepiandrosterone; Depression; HIV Infections; Humans; Neoplasms, Hormone-De

2001
Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients.
    Journal of the International Neuropsychological Society : JINS, 2001, Volume: 7, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Attention; Case-Control Studies; Cognition;

2001
Cortisol/DHEA ratios in depression.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 26, Issue:3

    Topics: Dehydroepiandrosterone; Depression; Female; Humans; Hydrocortisone

2002
Effect of prolactin on plasma DHEA (s) levels.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Dehydroepiandrosterone; Dementia; Depression; Estrogens; Female;

1977
Serum androgens and depression in women with facial hirsutism.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:2 Pt 1

    Topics: Adolescent; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Depression; Face; Female; Hir

1992
Urinary 17-ketosteroid fractionation in depression: a preliminary report.
    The British journal of psychiatry : the journal of mental science, 1969, Volume: 115, Issue:522

    Topics: 17-Ketosteroids; Adult; Androgens; Dehydroepiandrosterone; Depression; Humans; Hydrocortisone; Male;

1969
Urinary steroids in depressive illness.
    Scottish medical journal, 1971, Volume: 16, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Androsterone; Antidepressive Agents; Chroma

1971